TXG – 10x genomics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Days Volatility
Open
Prior Close

YTD

1 Day

TXG

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

4/21

05:52 am

txg

10x Genomics (TXG) was upgraded by Zacks Research from "hold" to "strong-buy".

Medium Report

10x Genomics (TXG) was upgraded by Zacks Research from "hold" to "strong-buy".

Report

4/20

12:18 pm

txg

10x Genomics (TXG) had its price target raised by Canaccord Genuity Group Inc. from $22.00 to $32.00. They now have a "buy" rating on the stock.

Low Report

10x Genomics (TXG) had its price target raised by Canaccord Genuity Group Inc. from $22.00 to $32.00. They now have a "buy" rating on the stock.

Report

4/20

11:45 am

txg

10x Genomics (TXG) had its price target raised by Bank of America Corporation from $21.00 to $30.00. They now have a "neutral" rating on the stock.

Medium Report

10x Genomics (TXG) had its price target raised by Bank of America Corporation from $21.00 to $30.00. They now have a "neutral" rating on the stock.

Report

4/18

11:35 pm

txg

10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood [Yahoo! Finance]

Medium Report

10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood [Yahoo! Finance]

Report

4/18

10:23 pm

txg

10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood [TheStreet.com]

Medium Report

10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood [TheStreet.com]

Report

4/18

10:00 pm

txg

10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood

Medium Report

10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood

Report

4/15

04:15 pm

txg

10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026 [TheStreet.com]

Low Report

10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026 [TheStreet.com]

Report

4/15

04:05 pm

txg

10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026

Low Report

10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026

Report

Date

Time

Symbol

Company Name

Action

%Chg

2/12/2026

04:09 pm

TXG

10x genomics, inc.

BEAT Report

3.2%

10x genomics, inc.

Report

11/6/2025

04:05 pm

TXG

10x genomics, inc.

BEAT Report

17.3%

10x genomics, inc.

Report

8/7/2025

04:05 pm

TXG

10x genomics, inc.

BEAT Report

-4.0%

10x genomics, inc.

Report

5/8/2025

04:05 pm

TXG

10x genomics, inc.

BEAT Report

1.0%

10x genomics, inc.

Report

Date

Time

Action

From

Firm

Impact

%Chg

4/20

12:16 pm

Maintains

Buy

Canaccord Genuity

Low

Report

-2.7%

Report

4/14

05:07 pm

Maintains

Overweight

Barclays

Medium

Report

3.8%

Report

4/14

05:07 pm

Maintains

Overweight

Barclays

Medium

Report

3.8%

Report

4/14

07:13 am

Reiterates

Overweight

Barclays PLC

Medium

Report

4.8%

Report

4/7

02:10 pm

Maintains

Neutral

Citigroup

Low

Report

-0.2%

Report

4/7

02:10 pm

Maintains

Neutral

Citigroup

Low

Report

-0.2%

Report

3/31

04:20 pm

Upgrades

Market Perform

Outperform

William Blair

Medium

Report

3.9%

Report

3/31

04:20 pm

Upgrades

Market Perform

Outperform

William Blair

Medium

Report

3.9%

Report

Date

Time

Symbol

Headline

Impact

4/16

04:07 pm

txg

Form 4 10x Genomics, Inc. For: Apr 14 Filed by: Saxonov Serge

Low Report

Form 4 10x Genomics, Inc. For: Apr 14 Filed by: Saxonov Serge

Report

3/25

05:15 pm

txg

Form 4 10x Genomics, Inc. For: Mar 23 Filed by: Saxonov Serge

Low Report

Form 4 10x Genomics, Inc. For: Mar 23 Filed by: Saxonov Serge

Report

3/25

03:07 pm

txg

Form SCHEDULE 13G/A 10x Genomics, Inc. Filed by: VANGUARD GROUP INC

Low Report

Form SCHEDULE 13G/A 10x Genomics, Inc. Filed by: VANGUARD GROUP INC

Report

3/24

04:15 pm

txg

Form SCHEDULE 13G/A 10x Genomics, Inc. Filed by: VANGUARD GROUP INC

Medium Report

Form SCHEDULE 13G/A 10x Genomics, Inc. Filed by: VANGUARD GROUP INC

Report

3/6

10:16 am

txg

Form SCHEDULE 13G/A 10x Genomics, Inc. Filed by: FMR LLC

Low Report

Form SCHEDULE 13G/A 10x Genomics, Inc. Filed by: FMR LLC

Report

3/4

04:14 pm

txg

Form 4 10x Genomics, Inc. For: Mar 02 Filed by: Saxonov Serge

Low Report

Form 4 10x Genomics, Inc. For: Mar 02 Filed by: Saxonov Serge

Report

3/2

04:25 pm

txg

Form 4 10x Genomics, Inc. For: Feb 26 Filed by: Saxonov Serge

Low Report

Form 4 10x Genomics, Inc. For: Feb 26 Filed by: Saxonov Serge

Report

3/2

04:24 pm

txg

Form 4 10x Genomics, Inc. For: Feb 26 Filed by: Hindson Benjamin J.

Low Report

Form 4 10x Genomics, Inc. For: Feb 26 Filed by: Hindson Benjamin J.

Report

Stock Stats

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings

Order Stats
Sub-Penny

Odd lot

Avg. bid-ask spread

Avg. bid-ask size

Shares at ask/bid

Off exchange

Main News & Impact Reports

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.